5Utech AE,Tadros EM,Hayes TG. Predicting survival in cancer patients:the role of cachexia and hormonal,nutritional and inflammatory markers[J].J Cachexia Sarcopenia Muscle,2012,(04):245-251.
6Soyfoo MS,Brenner K,Paesmans M. Non-malignant causes of hypercalcemia in cancer patients:a frequent and neglected occurrence[J].{H}SUPPORTIVE CARE IN CANCER,2013,(05):1415-1419.
7Torcia M,Lucibello M,Vannier E. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors[J].{H}EXPERIMENTAL HEMATOLOGY,1996,(08):868-874.
8Lorch G,Gilmore JL,Koltz PF. Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice[J].{H}British Journal of Cancer,2007,(02):183-193.
9Lumachi F,Brunello A,Roma A. Cancer-induced hypercalcemia[J].{H}Anticancer Research,2009,(05):1551-1555.
10Neville-Webbe HL,Coleman RE. Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease[J].{H}EUROPEAN JOURNAL OF CANCER,2010,(07):1211-1222.
